ConvaTec Group PLC (LON:CTEC) had its price target lifted by JPMorgan Chase & Co. from GBX 305 ($3.94) to GBX 318 ($4.10) in a note issued to investors on Friday, May 5th. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.’s price objective would suggest a potential upside of 6.00% from the company’s previous close.
A number of other analysts also recently issued reports on CTEC. Peel Hunt restated a “buy” rating and issued a GBX 300 ($3.87) price target on shares of ConvaTec Group PLC in a research report on Thursday, March 2nd. Deutsche Bank AG restated a “buy” rating on shares of ConvaTec Group PLC in a research report on Monday, February 27th. HSBC Holdings plc started coverage on ConvaTec Group PLC in a research report on Thursday, January 19th. They issued a “buy” rating and a GBX 310 ($4.00) price target for the company. Goldman Sachs Group Inc restated a “buy” rating and issued a GBX 310 ($4.00) price target on shares of ConvaTec Group PLC in a research report on Tuesday, March 21st. Finally, Morgan Stanley restated an “equal weight” rating on shares of ConvaTec Group PLC in a research report on Thursday, May 4th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of GBX 314 ($4.05).
Shares of ConvaTec Group PLC (LON:CTEC) opened at 300.00 on Friday. The stock’s 50 day moving average is GBX 292.36 and its 200-day moving average is GBX 255.46. ConvaTec Group PLC has a one year low of GBX 213.00 and a one year high of GBX 312.90. The company’s market cap is GBX 5.78 billion.
ILLEGAL ACTIVITY NOTICE: “JPMorgan Chase & Co. Increases ConvaTec Group PLC (CTEC) Price Target to GBX 318” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://sportsperspectives.com/2017/05/20/jpmorgan-chase-co-raises-convatec-group-plc-ctec-price-target-to-gbx-318-updated.html.
ConvaTec Group PLC Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.